Anti-VEGF therapy is known to effectively improve and maintain vision in most cases of advanced wet AMD [57,58,59], however repeated anti-VEGF injections may increase the risk of ocular and systemic complications [60,61]. This evidence concerns the gene VEGFA and wet macular degeneration.